HomePress-release

Redding, California - April 27, 2026

AI in Endoscopy Market to be Worth $19.7 Billion by 2036

AI in Endoscopy Market by AI Technology (Machine Learning & Deep Learning/Computer Vision/CADe/CADx, Natural Language Processing/Automated Reporting, Predictive Analytics & Decision Support), Component, Application (Gastrointestinal Endoscopy, Respiratory Endoscopy, Urological Endoscopy), Indication, Deployment Model, and End User — Global Opportunity Analysis and Industry Forecast (2026–2036)

Meticulous Research®—a leading global market research company, has published a research report titled, “AI in Endoscopy Market by AI Technology, Component, Application, Indication, Deployment Model, and End User — Global Opportunity Analysis and Industry Forecast (2026–2036)”

According to this latest publication from Meticulous Research®, the global AI in endoscopy market is projected to reach $19.7 billion by 2036, at a CAGR of 22.4% from 2026 to 2036. The market was valued at $1.85 billion in 2025 and is estimated at $2.31 billion in 2026.

Browse In-depth Table of Contents of the report Here: https://www.meticulousresearch.com/product/ai-in-endoscopy-market-6621/toc

The growth of the global AI in endoscopy market is primarily driven by the rapidly maturing clinical evidence base for AI-assisted colonoscopy, including the landmark COLO-DETECT randomized controlled trial documenting a 56.6% vs 48.4% adenoma detection rate (ADR) advantage for computer-aided detection (CADe)-assisted colonoscopy, combined with formal guideline endorsements from the American Gastroenterological Association (AGA) in March 2025 and the European Society of Gastrointestinal Endoscopy (ESGE) in 2025 incorporating AI into colonoscopy quality assurance frameworks; rising global colorectal cancer screening volumes with approximately 1.9 million new colorectal cancer cases annually driving high procedural demand; and the commercial deployment of FDA-cleared AI endoscopy platforms including Medtronic’s GI Genius (FDA de novo 2021), Olympus’s CADDIE 2 (FDA 510(k) July 2024), and Fujifilm’s CAD EYE demonstrating 9–16 percentage-point ADR improvements across randomized trials.

However, market growth is restrained by high upfront cost of AI-integrated endoscopy platforms and limited reimbursement frameworks for AI-assisted procedures in most markets outside the U.S., integration complexity with legacy endoscopy infrastructure and electronic medical record (EMR) systems, and clinician skepticism regarding AI false-positive rates disrupting procedural workflow. On the other hand, expanding AI endoscopy applications across Barrett’s esophagus surveillance, inflammatory bowel disease (IBD) activity scoring, AI-assisted cystoscopy for bladder cancer detection, capsule endoscopy automated video analysis, and AI-guided bronchoscopy for pulmonary nodule localization; growing ambulatory surgical center (ASC) adoption driven by the shift of routine colonoscopy to outpatient settings; and cloud-based AI platform deployment models lowering capital barriers represent significant growth opportunities.

Key trends include Olympus’s strategic transformation to an AI-led intelligent care platform via OLYSENSE CAD/AI, the rapid expansion of AI endoscopy beyond colonoscopy into adjacent GI and urological applications, and NLP-based automated endoscopy reporting gaining traction to reduce documentation burden.

The key players profiled in the AI in endoscopy market report include Medtronic plc (Ireland), Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), HOYA Corporation/Pentax Medical (Japan), Intuitive Surgical, Inc. (U.S.), Iterative Health (U.S.), Cosmo Intelligent Medical Devices/Linkverse (Ireland), Odin Vision Ltd. (UK/Olympus), Karl Storz SE & Co. KG (Germany), Wision AI Co., Ltd. (China), MAGENTIQ EYE Ltd. (Israel), Boston Scientific Corporation (U.S.), Ambu A/S (Denmark), and AI Medical Service Inc. (Japan), among others.

The AI in endoscopy market is segmented by AI Technology, Component, Application, Indication, Deployment Model, and End User. The report also evaluates industry competitors and analyzes the market at the regional and country levels.

Download Free Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6621

Among the AI technologies studied, the machine learning and deep learning (computer vision) segment is expected to hold the largest share in 2026, driven by the commercial deployment of CNN-based CADe and CADx systems including Medtronic’s GI Genius, Olympus’s CADDIE 2, and Fujifilm’s CAD EYE that perform real-time polyp detection and lesion characterization from live endoscopic video streams. The natural language processing (NLP) and automated reporting segment is projected to register the highest CAGR, as hospitals increasingly seek to automate time-intensive endoscopy documentation, extract structured quality metrics for ADR monitoring, and enable seamless EMR integration through AI-generated standardized procedure reports.

Among the applications studied, the gastrointestinal endoscopy segment is expected to hold the largest share in 2026, driven by AI-assisted colonoscopy’s robust randomized controlled trial evidence base, AGA and ESGE guideline endorsements, the very large global colorectal cancer screening program generating high procedure volumes, and the proven commercial deployment of multiple FDA-cleared CADe platforms. The urological endoscopy (cystoscopy) segment is projected to register the highest CAGR, driven by bladder cancer’s high recurrence rates creating substantial lifetime surveillance cystoscopy volumes, well-documented miss rates for flat and small lesions under standard white-light imaging, and the strong clinical logic for applying the proven AI CADe detection paradigm from colonoscopy to the structurally similar cystoscopy surveillance context.

Among the indications studied, the colorectal cancer and polyp detection indication is expected to hold the largest share in 2026, supported by the scale of the global colorectal cancer screening program, the COLO-DETECT trial evidence, and the AGA’s March 2025 formal CADe guidance establishing AI-assisted colonoscopy as a quality-enhancing standard. The gastric cancer and gastric lesions indication represents a large and fast-growing segment particularly in Asia-Pacific markets where gastric cancer incidence is 8–10-fold higher than in Western countries, with AI systems trained on Japanese and South Korean datasets being commercially deployed for early gastric cancer detection.

Among the end users studied, the hospitals and endoscopy centers segment is expected to hold the largest share in 2026, reflecting their role as the primary settings for high-volume and high-complexity endoscopic procedures with stronger capital budgets, established digital infrastructure, and access to skilled clinical personnel for AI system adoption. The ambulatory surgical centers (ASCs) segment is projected to register the highest CAGR, driven by the ongoing shift of routine colonoscopy procedures from inpatient hospital settings to lower-cost outpatient environments and ASCs’ growing use of AI-assisted endoscopy for quality differentiation, ADR benchmarking, and alignment with payer-driven quality programs.

Among the geographies studied, North America is expected to dominate the global AI in endoscopy market in 2026, driven by FDA regulatory precedence through GI Genius de novo clearance (2021) and subsequent CADDIE 2 510(k) clearance (2024), a dense commercial ecosystem of medtech companies and AI health startups, and strong clinical research infrastructure generating the trial evidence base driving institutional adoption. Asia-Pacific is projected to register the highest CAGR during the forecast period, driven by Japan and South Korea’s high endoscopy procedure volumes and leading AI hardware developers Olympus and Fujifilm, China’s position as the global leader in AI digestive endoscopy research, and India’s rapidly expanding private hospital advanced endoscopy infrastructure.

Key Questions Answered in the Report:

What is the size of the global AI in endoscopy market, and at what CAGR is it projected to grow during 2026 to 2036?
Which are the high-growth segments in terms of AI technology, component, application, indication, deployment model, end user, and geography?
What are the major drivers, restraints, opportunities, challenges, and trends in the global AI in endoscopy market?
Who are the major players and what are their competitive strategies in the AI in endoscopy industry?
What are the recent regulatory clearances, clinical trial results, product launches, and strategic partnerships among key market participants?
What is the regional and country-level market outlook, and which geographies are expected to register the highest growth rates?
How are CADe/CADx platform adoption, AGA/ESGE guideline endorsements, NLP-based automated reporting, AI cystoscopy, cloud-based deployment, and ASC market expansion reshaping the global AI in endoscopy landscape through 2036?

About Meticulous Research®

Founded in 2010, Meticulous Research® is a global market research and consulting firm with over 15 years of experience delivering actionable intelligence across industries, including healthcare, information technology, semiconductors & electronics, food & beverages, and energy. The company provides syndicated research, custom research, and consulting services, leveraging a robust combination of primary and secondary research methodologies. The firm works with a wide spectrum of organizations worldwide, ranging from high-growth companies to global enterprises, private equity firms, governments, and academic institutions. With a strong global presence, the firm serves clients across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, enabling organizations to identify growth opportunities, assess competitive landscapes, and make informed strategic decisions.

To find out more, visit www.meticulousresearch.com or follow us on Twitter, LinkedIn, and Facebook.

Contact Us:

Mr. Rajesh Patil

Meticulous Research®

21267 Willis St, Ste 200

Redding, California, 96001

Email: sales@meticulousresearch.com

US: +1-646-781-8004

Europe: +44-203-868-8738

APAC: +91-744-778-0008

Website: www.meticulousresearch.com

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Industrial Infrastructure

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & WastewaterTechnologies

Miscellaneous / Others

Redding, California - April 27, 2026

AI in Endoscopy Market to be Worth $19.7 Billion by 2036

About Meticulous Research®

Contact Us:

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies